US Stock MarketDetailed Quotes

OGN Organon & Co

Watchlist
  • 15.280
  • -1.040-6.37%
Close Feb 14 16:00 ET
  • 15.350
  • +0.070+0.46%
Post 20:01 ET
3.94BMarket Cap4.59P/E (TTM)

About Organon & Co Company

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Company Profile

SymbolOGN
Company NameOrganon & Co
Listing DateMay 14, 2021
Founded2020
CEOMr. Kevin Ali
MarketNYSE
Employees10000
Fiscal Year Ends12-31
Address30 Hudson Street,33rd floor
CityJersey City
ProvinceNew Jersey
CountryUnited States of America
Zip Code07302
Phone1-551-430-6900
Websitehttp://www.organon.com

Company Executives

  • Name
  • Position
  • Salary
  • Kevin Ali
  • Chief Executive Officer and Director
  • 14.83M
  • Matthew M. Walsh
  • Executive Vice President and Chief Financial Officer
  • 5.21M
  • Aaron Falcione
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Rachel A. Stahler
  • Executive Vice President and Chief Information Officer
  • --
  • Dr. Juan Camilo Arjona Ferreira, M.D.
  • Executive Vice President, Head of Research and Development and Chief Medical Officer
  • --
  • Vittorio Nisita
  • Executive Vice President and Head of Global Business Services
  • --
  • Kirke Weaver
  • Executive Vice President, General Counsel and Corporate Secretary
  • 3.19M
  • Joseph T. Morrissey, Jr
  • Executive Vice President and Head of Manufacturing and Supply
  • 3.74M
  • Carrie S. Cox
  • Chairman of the Board
  • 450.00K
  • Dr. Helene D. Gayle, M.D.
  • Independent Director
  • 320.00K
  • Rochelle B. Lazarus
  • Independent Director
  • 320.00K
  • Deborah R. Leone
  • Independent Director
  • 330.00K
  • Dr. Phillip Ozuah, M.D.,PhD
  • Independent Director
  • 320.00K
  • Shalini Sharp
  • Independent Director
  • 345.00K
  • Grace Puma Whiteford
  • Independent Director
  • 320.00K
  • Cynthia M. Patton
  • Independent Director
  • 330.00K
  • Robert A. Essner
  • Independent Director
  • 335.00K
  • Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
  • Independent Director
  • 330.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
HNAC Technology
300490
+19.95%
4
TFL
873152
+15.66%
5
Shenzhen Chengtian Weiye Technology
300689
+13.51%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?